TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Researchers report that the enzyme-producing gene Pla2g2f helped preserve memory and limit several signs of brain aging in mice. Its activity also reduced lipid buildup in human microglia in laboratory experiments, but whether it can be safely used to prevent cognitive decline in people is unknown.
A study published in Nature Neuroscience reports that increasing activity of the brain gene Pla2g2f protected aging mice against memory impairment and several other changes linked to brain aging. The researchers also found reduced lipid accumulation in human microglia in laboratory experiments, but the findings do not show that the approach prevents cognitive decline in people or is ready for treatment.
Lead author Cinzia Vicidomini and senior author Amar Sahay, of Mass General Brigham, the Harvard Stem Cell Institute and the Broad Institute, studied genes activated in response to loss of hippocampal synapses in mice. The hippocampus is important for memory, and synapse loss is associated with age-related cognitive decline. The team identified Pla2g2f, which produces a secreted enzyme called a phospholipase; its role in the brain had not previously been established.
The researchers report that Pla2g2f levels rose in the hippocampus as mice aged and during brain inflammation. They also observed increased levels in older adults whose brains showed signs of Alzheimer’s disease pathology despite their remaining cognitively resilient. That human observation is an association, not evidence that the enzyme caused resilience.
In aging mice, reducing Pla2g2f worsened several measures, including synapse loss, inflammation, the maturation of new brain cells, lipid metabolism, lipid-droplet accumulation and memory. Increasing the gene’s activity protected against many of those effects. The team says boosting it in middle-aged mice, before substantial cognitive decline, changed the course of age-related memory loss. Separately, increasing Pla2g2f activity in human microglia reduced lipid droplets and cholesterol esters in laboratory experiments.
A Possible Route to Memory Resilience
The findings point to a biological pathway that may help explain why some brains maintain cognitive function despite age-related changes or Alzheimer’s-related pathology. The study links Pla2g2f with several processes at once, including synapse maintenance, inflammation and lipid handling in brain immune cells. This gives researchers a candidate mechanism to investigate, rather than evidence of a treatment that patients can use now.
Aging is a major risk factor for Alzheimer’s disease, but the experiments do not establish that raising Pla2g2f in people would delay mild cognitive impairment or Alzheimer’s. The mouse results and laboratory work in human cells provide a basis for further research; they do not establish clinical benefit, an effective dose or safety. The distinction matters because a potential target in early research is not the same as a proven preventive therapy.
nootropic supplements for memory support
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
How the Researchers Identified Pla2g2f
The study began with the hippocampus, where synapse loss is associated with memory decline as animals age. Researchers looked for genes activated in response to that loss, then used genetic and viral methods to raise or lower Pla2g2f in aging mice. This approach let them test how changing the gene affected brain and memory measures, although animal findings cannot by themselves predict outcomes in people.
The paper, An aging-sensitive secreted phospholipase confers neuroprotection and cognitive resilience, was published in 2026. Its authors describe lipid droplets in microglia as one feature of aging-related brain changes: these immune cells can become less effective at clearing waste and supporting neurons as droplets accumulate. The work examines whether Pla2g2f may influence that process as well as synaptic health.
“We sought to identify the protective factors that contribute to cognitive resilience during aging.”
— Cinzia Vicidomini and Amar Sahay, study authors
brain health supplements for aging
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Human Benefits Remain Unproven
The reported memory protection came from experiments in aging mice, while the human-cell experiments measured lipid-related changes in microglia. Neither establishes that increasing Pla2g2f improves memory or prevents disease in people. The report does not provide evidence from a clinical trial, nor does it establish how the enzyme could be safely increased in the human brain.
It is also unclear whether the higher Pla2g2f levels observed in cognitively resilient older adults helped preserve cognition, arose in response to disease-related changes, or reflected another factor. The study’s findings support further investigation, but they do not settle that question or show how the pathway might affect different stages of cognitive impairment.
As an affiliate, we earn on qualifying purchases.
Research Must Test Safety and Delivery
The authors say they are exploring ways to increase Pla2g2f levels in the aging brain and in Alzheimer’s disease. Further work will need to determine whether those methods can reach the relevant brain cells, produce an appropriate level of enzyme activity and avoid harmful effects. The source report does not give a timetable for clinical testing.
For now, the next step is research that tests whether the results hold across additional experiments and whether a safe, effective approach can be developed for people. Until clinical evidence is available, Pla2g2f remains a research target, not an established way to prevent or treat memory loss.
cognitive decline prevention supplements
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What is Pla2g2f?
Pla2g2f is a gene that produces a secreted enzyme called a phospholipase. Researchers in this study investigated its previously unknown role in the brain.
Did the enzyme prevent memory decline in people?
No. The reported memory effects were found in aging mice. Human experiments involved microglia in a laboratory setting and measured lipid accumulation, not memory or clinical outcomes.
What brain changes were linked to increased Pla2g2f in mice?
The researchers report protection against several changes, including synapse loss, inflammation, disrupted lipid metabolism and memory impairment. The results are from animal experiments and do not establish that the same effects occur in people.
Could Pla2g2f lead to an Alzheimer’s treatment?
The study identifies a possible research target, but no Pla2g2f-based treatment is established. The authors say more work is needed to determine whether the approach can be safely translated into therapies for patients.
Source: rss
Cold & flu season Picks
humidifiers
As an affiliate, we earn on qualifying purchases.
